NCT04020211 (CPSP-3) is a clinical trial of Senza HF10 Therapy in Chronic Pain Post-Procedural, sponsored by Nevro Corp.

Who is sponsoring NCT04020211?

NCT04020211 is sponsored by Nevro Corp.

What drugs are being tested in NCT04020211?

Interventions in NCT04020211: Senza HF10 Therapy.

What condition does NCT04020211 study?

NCT04020211 studies Chronic Pain Post-Procedural.

Is NCT04020211 still recruiting?

NCT04020211 is currently terminated. Last updated 12 November 2020.

Last reviewed 2020-11-12 · How we verify

NCT04020211: CPSP-3

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

HF10 Treatment of Chronic Knee Pain

Terminated Last updated 12 November 2020

What this trial tests

trial testing Senza HF10 Therapy in Chronic Pain Post-Procedural in 3 participants. Terminated before completion.

Timeline

14 March 2019

Primary endpoint
12 December 2019

12 December 2019

Quick facts

Lead sponsor	Nevro Corp
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	3
Start date	14 March 2019
Primary completion	12 December 2019
Estimated completion	12 December 2019
Sites	1 location across United States

Drugs / interventions tested

Senza HF10 Therapy

Conditions studied

Chronic Pain Post-Procedural — all drugs for Chronic Pain Post-Procedural →

Sponsor

Nevro Corp

Who can join

18 and older, any sex, with Chronic Pain Post-Procedural. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a multi-center study where patients who meet the eligibility criteria will be treated with HF10 therapy for their chronic knee pain post-orthopedic surgery. The primary endpoint will be assessed at 3 months, but observational assessments will continue until study completion at 12 months following implant.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Senza HF10 Therapy

Trials testing the same drug.

NCT03228420 — Comparison of 10 kHz SCS Combined With CMM to CMM Alone in the Treatment of Neuropathic Limb Pain · NA · unknown

Other Nevro Corp trials

Trials by the same sponsor.

NCT05777317 — Pain and Neurological Function Improvements With 10 kHz Spinal Cord Stimulation Treatment of Painful Diabetic Neuropathy · NA · active not recruiting
NCT03228420 — Comparison of 10 kHz SCS Combined With CMM to CMM Alone in the Treatment of Neuropathic Limb Pain · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04020211 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nevro Corp
Last refreshed: 12 November 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04020211.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing